Visium Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Visium Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-83	Closed	-$333K	–	1239
2015 Q2	$333K	Sell	83 -978	-92%	-$3.78M	﹤0.01%	767
2015 Q1	$4.24M	Sell	1,061 -7,725	-88%	-$35.4M	0.06%	297
2014 Q4	$43.1M	Buy	8,786 +4,369	+99%	+$18.7M	0.61%	28
2014 Q3	$18M	Buy	+4,417	New	+$16.6M	0.27%	78
2014 Q1	–	Sell	-240	Closed	-$840K	–	1062
2013 Q4	$840K	Sell	240 -28	-10%	-$109K	0.02%	476
2013 Q3	$1.1M	Buy	268 +140	+109%	+$603K	0.03%	406
2013 Q2	$506K	Buy	+128	New	+$527K	0.01%	471

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's ACOR Position: Q3 2015 in Review

Visium Asset Management sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 83 shares — an estimated $333K sold.

Visium Asset Management first reported a position in ACOR in Q2 2013 and held it in 7 quarters. The position peaked at $43.1M in Q4 2014. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

Visium Asset Management reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 83 Acorda Therapeutics shares in Q3 2015, an estimated $333K.
Visium Asset Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 7 quarters.
Visium Asset Management's Acorda Therapeutics position peaked at $43.1M in Q4 2014.
176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.